ATI RN PHARMACOLOGY PROCTORED EXAM
2026 – 200 PRACTICE QUESTIONS
ABOUT THIS RESOURCE
This comprehensive test bank is designed for students preparing for
the ATI RN Pharmacology Proctored Exam 2026. The exam is a
comprehensive assessment that evaluates nursing students' knowledge of
pharmacological principles across all content areas.
SECTION 1: PHARMACOLOGICAL PRINCIPLES
(Questions 1–30)
Question 1: A nurse is teaching a patient about a new medication. The
patient asks what it means when a medication has a half-life of 12 hours.
Which response is most accurate?
A) "The medication will be completely eliminated from your body in 12
hours."
B) "It takes 12 hours for the medication concentration in your body to
decrease by 50%."
C) "You should take the medication every 12 hours."
D) "The medication reaches its peak effect in 12 hours."
Correct Answer: B) It takes 12 hours for the medication concentration
in your body to decrease by 50%.
,Rationale: Half-life is the time required for the serum drug concentration to
decrease by 50%. It takes approximately 4-5 half-lives for a drug to be
eliminated from the body. Half-life determines dosing intervals and time to
reach steady-state. It does not mean the medication is completely eliminated
(A) or that dosing should be every 12 hours (C).
Question 2: The nurse is preparing to administer a medication that is
known to be highly protein-bound. Which consideration should the nurse
prioritize?
A) The medication will have a rapid onset of action
B) The medication will be rapidly excreted by the kidneys
C) Competition with other protein-bound drugs can increase free drug
levels and risk of toxicity
D) The medication will not be absorbed from the GI tract
Correct Answer: C) Competition with other protein-bound drugs can
increase free drug levels and risk of toxicity
Rationale: When two highly protein-bound drugs are given together, they
compete for binding sites on plasma proteins, increasing the free (active)
fraction of the displaced drug and the risk of toxicity. Highly protein-bound
drugs tend to have longer half-lives and smaller volumes of distribution.
Question 3: A patient is prescribed a medication that is a CYP450 enzyme
inducer. The nurse should monitor for which effect on other medications?
A) Increased serum levels and toxicity
B) Decreased serum levels and reduced effectiveness
C) No effect on other medications
D) Increased protein binding of other medications
,Correct Answer: B) Decreased serum levels and reduced effectiveness
Rationale: CYP450 inducers increase the metabolism of other drugs that are
substrates for the same enzyme, leading to lower serum concentrations and
decreased therapeutic effects. Examples of inducers include rifampin,
phenytoin, carbamazepine, and St. John's wort.
Question 4: A patient is prescribed a medication that is a CYP450 inhibitor.
The nurse should monitor for which effect on other medications?
A) Decreased serum levels and reduced effectiveness
B) Increased serum levels and toxicity
C) No effect on other medications
D) Decreased protein binding of other medications
Correct Answer: B) Increased serum levels and toxicity
Rationale: CYP450 inhibitors decrease the metabolism of other drugs that are
substrates for the same enzyme, leading to higher serum concentrations and
increased risk of toxicity. Examples of CYP450 inhibitors include ketoconazole,
erythromycin, and grapefruit juice.
Question 5: A patient with hepatic impairment is prescribed a medication
that undergoes extensive first-pass metabolism. What adjustment is most
appropriate?
A) Increase the dose
B) Decrease the dose or use an alternative route
C) No adjustment is needed
D) Increase the dosing frequency
Correct Answer: B) Decrease the dose or use an alternative route
, Rationale: Drugs that undergo extensive first-pass metabolism (e.g.,
propranolol, morphine, nitroglycerin) have reduced bioavailability when
given orally. In hepatic impairment, first-pass metabolism is reduced, leading
to increased bioavailability and risk of toxicity. Dose reduction or alternative
routes (IV, sublingual) may be needed.
Question 6: Which route of administration bypasses first-pass metabolism?
A) Oral tablet
B) Sublingual
C) Intramuscular
D) Both B and C
Correct Answer: D) Both B and C
Rationale: Sublingual, buccal, intravenous, intramuscular, and transdermal
routes bypass first-pass metabolism because the drug does not pass through
the hepatic portal circulation before reaching systemic circulation. Oral
administration is subject to first-pass metabolism in the liver.
Question 7: A drug with a narrow therapeutic index requires which of the
following?
A) No special monitoring
B) Regular monitoring of plasma drug levels
C) Once-daily dosing only
D) Administration with a high-fat meal
Correct Answer: B) Regular monitoring of plasma drug levels
Rationale: Drugs with a narrow therapeutic index (e.g., digoxin, lithium,
warfarin, phenytoin) have a small margin between therapeutic and toxic
2026 – 200 PRACTICE QUESTIONS
ABOUT THIS RESOURCE
This comprehensive test bank is designed for students preparing for
the ATI RN Pharmacology Proctored Exam 2026. The exam is a
comprehensive assessment that evaluates nursing students' knowledge of
pharmacological principles across all content areas.
SECTION 1: PHARMACOLOGICAL PRINCIPLES
(Questions 1–30)
Question 1: A nurse is teaching a patient about a new medication. The
patient asks what it means when a medication has a half-life of 12 hours.
Which response is most accurate?
A) "The medication will be completely eliminated from your body in 12
hours."
B) "It takes 12 hours for the medication concentration in your body to
decrease by 50%."
C) "You should take the medication every 12 hours."
D) "The medication reaches its peak effect in 12 hours."
Correct Answer: B) It takes 12 hours for the medication concentration
in your body to decrease by 50%.
,Rationale: Half-life is the time required for the serum drug concentration to
decrease by 50%. It takes approximately 4-5 half-lives for a drug to be
eliminated from the body. Half-life determines dosing intervals and time to
reach steady-state. It does not mean the medication is completely eliminated
(A) or that dosing should be every 12 hours (C).
Question 2: The nurse is preparing to administer a medication that is
known to be highly protein-bound. Which consideration should the nurse
prioritize?
A) The medication will have a rapid onset of action
B) The medication will be rapidly excreted by the kidneys
C) Competition with other protein-bound drugs can increase free drug
levels and risk of toxicity
D) The medication will not be absorbed from the GI tract
Correct Answer: C) Competition with other protein-bound drugs can
increase free drug levels and risk of toxicity
Rationale: When two highly protein-bound drugs are given together, they
compete for binding sites on plasma proteins, increasing the free (active)
fraction of the displaced drug and the risk of toxicity. Highly protein-bound
drugs tend to have longer half-lives and smaller volumes of distribution.
Question 3: A patient is prescribed a medication that is a CYP450 enzyme
inducer. The nurse should monitor for which effect on other medications?
A) Increased serum levels and toxicity
B) Decreased serum levels and reduced effectiveness
C) No effect on other medications
D) Increased protein binding of other medications
,Correct Answer: B) Decreased serum levels and reduced effectiveness
Rationale: CYP450 inducers increase the metabolism of other drugs that are
substrates for the same enzyme, leading to lower serum concentrations and
decreased therapeutic effects. Examples of inducers include rifampin,
phenytoin, carbamazepine, and St. John's wort.
Question 4: A patient is prescribed a medication that is a CYP450 inhibitor.
The nurse should monitor for which effect on other medications?
A) Decreased serum levels and reduced effectiveness
B) Increased serum levels and toxicity
C) No effect on other medications
D) Decreased protein binding of other medications
Correct Answer: B) Increased serum levels and toxicity
Rationale: CYP450 inhibitors decrease the metabolism of other drugs that are
substrates for the same enzyme, leading to higher serum concentrations and
increased risk of toxicity. Examples of CYP450 inhibitors include ketoconazole,
erythromycin, and grapefruit juice.
Question 5: A patient with hepatic impairment is prescribed a medication
that undergoes extensive first-pass metabolism. What adjustment is most
appropriate?
A) Increase the dose
B) Decrease the dose or use an alternative route
C) No adjustment is needed
D) Increase the dosing frequency
Correct Answer: B) Decrease the dose or use an alternative route
, Rationale: Drugs that undergo extensive first-pass metabolism (e.g.,
propranolol, morphine, nitroglycerin) have reduced bioavailability when
given orally. In hepatic impairment, first-pass metabolism is reduced, leading
to increased bioavailability and risk of toxicity. Dose reduction or alternative
routes (IV, sublingual) may be needed.
Question 6: Which route of administration bypasses first-pass metabolism?
A) Oral tablet
B) Sublingual
C) Intramuscular
D) Both B and C
Correct Answer: D) Both B and C
Rationale: Sublingual, buccal, intravenous, intramuscular, and transdermal
routes bypass first-pass metabolism because the drug does not pass through
the hepatic portal circulation before reaching systemic circulation. Oral
administration is subject to first-pass metabolism in the liver.
Question 7: A drug with a narrow therapeutic index requires which of the
following?
A) No special monitoring
B) Regular monitoring of plasma drug levels
C) Once-daily dosing only
D) Administration with a high-fat meal
Correct Answer: B) Regular monitoring of plasma drug levels
Rationale: Drugs with a narrow therapeutic index (e.g., digoxin, lithium,
warfarin, phenytoin) have a small margin between therapeutic and toxic
